Reversal of lupus-erythematosus-like disease with danazol.
D000328:Adult; D003174:Complement C1 Inactivator Proteins / Q000032:analysis; D003181:Complement C4 / Q000032:analysis; D003613:Danazol / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D011245:Pregnadienes / Q000627:therapeutic use*
D003174:Complement C1 Inactivator Proteins; D003181:Complement C4; D011245:Pregnadienes; D003613:Danazol